PetMed Express (Nasdaq: PETS) is expected to report Q2 earnings on Oct. 22. Here's what Wall Street wants to see:

The 10-second takeaway
 Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict PetMed Express's revenues will drop -2.0% and EPS will wither -10.5%.

The average estimate for revenue is $57.0 million. On the bottom line, the average EPS estimate is $0.17.

Revenue details
 Last quarter, PetMed Express tallied revenue of $69.0 million. GAAP reported sales were 6.3% lower than the prior-year quarter's $73.6 million.

Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.

EPS details
 Last quarter, EPS came in at $0.20. GAAP EPS of $0.20 for Q1 were 9.1% lower than the prior-year quarter's $0.22 per share.

Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.

Recent performance
 For the preceding quarter, gross margin was 32.3%, 50 basis points worse than the prior-year quarter. Operating margin was 9.0%, 130 basis points worse than the prior-year quarter. Net margin was 5.7%, 90 basis points worse than the prior-year quarter.

Looking ahead

The full year's average estimate for revenue is $230.0 million. The average EPS estimate is $0.71.

Investor sentiment
 The stock has a four-star rating (out of five) at Motley Fool CAPS, with 873 members out of 901 rating the stock outperform, and 28 members rating it underperform. Among 202 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 193 give PetMed Express a green thumbs-up, and nine give it a red thumbs-down.

Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on PetMed Express is underperform, with an average price target of $10.80.

Can your portfolio provide you with enough income to last through retirement? You'll need more than PetMed Express. Learn how to maximize your investment income and get "The 3 DOW Stocks Dividend Investors Need." Click here for instant access to this free report.